WO2015149392A1 - Préparation d'un médicament traditionnel chinois destiné à traiter une colite chronique et son procédé de préparation - Google Patents
Préparation d'un médicament traditionnel chinois destiné à traiter une colite chronique et son procédé de préparation Download PDFInfo
- Publication number
- WO2015149392A1 WO2015149392A1 PCT/CN2014/075339 CN2014075339W WO2015149392A1 WO 2015149392 A1 WO2015149392 A1 WO 2015149392A1 CN 2014075339 W CN2014075339 W CN 2014075339W WO 2015149392 A1 WO2015149392 A1 WO 2015149392A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- asparagus
- chinese medicine
- licorice
- traditional chinese
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 45
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 206010009887 colitis Diseases 0.000 title claims abstract description 20
- 230000001684 chronic effect Effects 0.000 title claims abstract description 17
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 20
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 18
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 18
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 18
- 229940010454 licorice Drugs 0.000 claims abstract description 18
- 244000236658 Paeonia lactiflora Species 0.000 claims abstract description 15
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 15
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 14
- 241001673966 Magnolia officinalis Species 0.000 claims abstract description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 7
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 7
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 4
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract 6
- 241001522232 Pinellia ternata Species 0.000 claims abstract 4
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract 3
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract 3
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract 3
- 230000000694 effects Effects 0.000 claims description 22
- 244000179970 Monarda didyma Species 0.000 claims description 19
- 235000010672 Monarda didyma Nutrition 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 18
- 241000234427 Asparagus Species 0.000 claims description 17
- 235000004879 dioscorea Nutrition 0.000 claims description 17
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 16
- 241001522129 Pinellia Species 0.000 claims description 16
- 235000006533 astragalus Nutrition 0.000 claims description 14
- 241001061264 Astragalus Species 0.000 claims description 13
- 210000004233 talus Anatomy 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 241000218176 Corydalis Species 0.000 claims description 9
- 210000000988 bone and bone Anatomy 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 6
- 241000202807 Glycyrrhiza Species 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- 244000205574 Acorus calamus Species 0.000 claims 5
- 241001079251 Euodia Species 0.000 claims 4
- 241000405414 Rehmannia Species 0.000 claims 4
- 235000006480 Acorus calamus Nutrition 0.000 claims 3
- 235000002723 Dioscorea alata Nutrition 0.000 claims 3
- 235000005362 Dioscorea floribunda Nutrition 0.000 claims 3
- 235000004868 Dioscorea macrostachya Nutrition 0.000 claims 3
- 235000005361 Dioscorea nummularia Nutrition 0.000 claims 3
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 claims 3
- 239000008213 purified water Substances 0.000 claims 3
- 244000003416 Asparagus officinalis Species 0.000 claims 2
- 235000011996 Calamus deerratus Nutrition 0.000 claims 2
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims 2
- 244000197580 Poria cocos Species 0.000 claims 2
- 235000008599 Poria cocos Nutrition 0.000 claims 2
- 241000271309 Aquilaria crassna Species 0.000 claims 1
- 235000007056 Dioscorea composita Nutrition 0.000 claims 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 claims 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 claims 1
- 240000004658 Medicago sativa Species 0.000 claims 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims 1
- 244000237986 Melia azadirachta Species 0.000 claims 1
- 235000013500 Melia azadirachta Nutrition 0.000 claims 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims 1
- 244000184734 Pyrus japonica Species 0.000 claims 1
- 241000405911 Rehmannia glutinosa Species 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 238000002156 mixing Methods 0.000 abstract description 3
- 241000045403 Astragalus propinquus Species 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 241000242759 Actiniaria Species 0.000 abstract 1
- 244000248539 Asparagus cochinchinensis Species 0.000 abstract 1
- 235000009292 Asparagus cochinchinensis Nutrition 0.000 abstract 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 241000830532 Corydalis yanhusuo Species 0.000 abstract 1
- 241000657528 Dalbergia odorifera Species 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 241001078983 Tetradium ruticarpum Species 0.000 abstract 1
- 241001619454 Wolfiporia Species 0.000 abstract 1
- 238000002481 ethanol extraction Methods 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 24
- 208000002193 Pain Diseases 0.000 description 19
- 210000002784 stomach Anatomy 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 230000036407 pain Effects 0.000 description 18
- 208000004998 Abdominal Pain Diseases 0.000 description 15
- 206010012735 Diarrhoea Diseases 0.000 description 15
- 206010062717 Increased upper airway secretion Diseases 0.000 description 15
- 208000026435 phlegm Diseases 0.000 description 15
- 241000219061 Rheum Species 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 13
- 241000218378 Magnolia Species 0.000 description 12
- 239000008678 sanqi Substances 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 206010011224 Cough Diseases 0.000 description 11
- 239000000835 fiber Substances 0.000 description 11
- 238000002052 colonoscopy Methods 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 10
- 206010047700 Vomiting Diseases 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 230000008673 vomiting Effects 0.000 description 8
- 206010036790 Productive cough Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 238000001784 detoxification Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 208000024794 sputum Diseases 0.000 description 7
- 210000003802 sputum Anatomy 0.000 description 7
- 208000032023 Signs and Symptoms Diseases 0.000 description 6
- 206010042674 Swelling Diseases 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 230000009856 intestinal mucosal lesion Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 206010000060 Abdominal distension Diseases 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 241000221089 Jatropha Species 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 241001247821 Ziziphus Species 0.000 description 4
- 208000024330 bloating Diseases 0.000 description 4
- 208000027503 bloody stool Diseases 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 208000035861 hematochezia Diseases 0.000 description 4
- 210000003097 mucus Anatomy 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 230000000306 recurrent effect Effects 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 241001466532 Pelecanus erythrorhynchos Species 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 239000000571 coke Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 241001674044 Blattodea Species 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010008469 Chest discomfort Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010017999 Gastrointestinal pain Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 229940100688 oral solution Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000008575 shengdi Substances 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 108010087765 Antipain Proteins 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010015995 Eyelid ptosis Diseases 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000008081 Intestinal Fistula Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 244000182216 Mimusops elengi Species 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- 206010028140 Mucous stools Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000019229 Spleen disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- SDNYTAYICBFYFH-TUFLPTIASA-N antipain Chemical compound NC(N)=NCCC[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SDNYTAYICBFYFH-TUFLPTIASA-N 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000024753 bloody sputum Diseases 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000019604 hot taste sensations Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000018962 mouth sore Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000003004 ptosis Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 208000027140 splenic disease Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Definitions
- the invention relates to a traditional Chinese medicine preparation for treating colitis, in particular to a traditional Chinese medicine preparation for treating chronic colitis and a preparation method thereof.
- the intestine refers to the digestive tract from the pylorus of the stomach to the anus.
- the intestine is the longest part of the digestive tract and the most important part of the function.
- the intestine is the largest digestive organ of the human body and the largest detoxification organ in the human body. From the perspective of physiology, anatomy, and cytology, large intestine detoxification accounts for more than 85 % of human detoxification; 80% of the human body's immune structure is around the intestine, and endotoxin accumulation is the killer of autoimmune immunity.
- Chronic colitis is a common disease. Clinical manifestations include increased frequency of stools, no grain, or watery or sticky, accompanied by bowel, abdominal pain, and even spleen and kidney.
- the general disease is in the intestine, but it involves the spleen, stomach, liver, kidney and other organs. It will be thin and burnout for a long time.
- This card is one of the common spleen and stomach diseases in the clinic. It has a high incidence rate, easy recurrence, and lingering, which seriously affects people's normal life, and the cancer rate is about 5%.
- the object of the present invention is to provide a traditional Chinese medicine preparation for treating chronic colitis based on the above-mentioned deficiencies, combined with modern Chinese and Western medicine technology, and in particular to provide such a traditional Chinese medicine preparation and a preparation method thereof, the present invention
- the treatment of colitis is obvious, and it is non-toxic, has no side effects, and has stable effects.
- the preparation process is simple and easy.
- the preparation of the invention is from Magnolia officinalis, Poria, Evodia, Radix Astragali, Radix Glycyrrhizae, Radix Notoginseng, Rhubarb, Radix Paeoniae Alba, Bergamot, Yam, Chuanxiongzi, Jiangxiang, Jatropha, Asparagus, Skull, Pinellia, Yanhusuo, Shengdi And a preparation of a composition prepared from red dates, wherein the mass ratio of each component is: Magnolia 12-20g ⁇ 10-22g Wu Wei
- the preferred raw materials of the present invention is: Magnolia 12-18g ⁇ 10-18g Wujing 8-12g Astragalus 12-18g Licorice 8-12g Sanqi 10-15g Rhubarb 8-12g White peony 12-16g bergamot 8-12g yam 10-15g medlar 10-14g 10-15g
- the present invention is also preferable to the raw material of Magnolia 15g ⁇ 12g Wujing 9g Astragalus 15g Licorice 10g Sanqi 12g Rhubarb 12g White peony 10g Bergamot 8g Yam 12g Chuanxiong 14g Fragrance 12g Iris 8g asparagus 8g thief bone 12g pinellia 10g yanhusuo 8g habitat 10g jujube 15g c
- the above preparation method for treating a chronic colitis traditional Chinese medicine preparation comprises the following steps:
- step 3 mix the powders of each component in step 1) and 2), add boiling water twice, add 10 times pure water for 1 hour, extract the filtrate for use; 6 times pure water decoction for half an hour, then combine the decoction and filter, spare; 4), the remaining Sanqi, Yam, Chuanxiongzi, Jiangxiang, Iris, asparagus, ribs, and raw land are proportioned well, crushed into powder by a pulverizer and passed through a 80 mesh sieve, and dried naturally. spare;
- step 5 mixing the powders of each component in step 4), adding 4 to 6 times 70% ⁇ 80% ethanol, heating and refluxing for 3 to 5 hours, extracting and filtering to obtain a filtrate; and then remaining the dregs Adding 2 to 4 times of 65% to 75% ethanol again, heating and refluxing for 2 to 3 hours, extracting and filtering to obtain a filtrate; combining the filtrates obtained twice, removing the ethanol solvent under reduced pressure, and drying to obtain a dry paste. ;
- the dry paste obtained in the above step 5) is ultra-pulverized into a powder and passed through a 200 mesh sieve, and then the powder is added to 3) the combined decoction in the step, and the mixture is shaken to obtain.
- the prepared Chinese medicine composition solution preparation can be used for oral administration, and if it can be consumed once in the morning and evening, and it is used for a long time, the effect is better.
- the theoretical basis of the present invention is: Magnolia, a medicinal plant belonging to the family Magnoliaceae, and the growth region is mainly in Sichuan, Hubei and the like. Indications of food stagnation, abdominal distension constipation, wet resistance in the coke, vomiting and diarrhea, suffocating, chest full of asthma and cough and other symptoms. It has the effects of stagnation of phlegm and blood stasis, qi and asthma, phlegm and phlegm, and dispelling wind and analgesia.
- Decoction has a broad-spectrum antibacterial effect, inhibiting Staphylococcus aureus, hemolytic streptococcus, diphtheria bacilli in vitro; in addition, Magnolia also regulates smooth muscle, anti-ulcer, central inhibition, blood pressure lowering, anti-pathogenic microorganisms , anti-tumor and other effects.
- ⁇ sweet, light, flat, medicine has the benefit of water and moisture, spleen and stomach, Ningxin and soothe the nerves, attending urinary unfavorable, edema full, sputum cough, vomiting, modern medical research: ⁇ can enhance the body The immune function, ⁇ polysaccharide has obvious anti-tumor and liver-preserving effects.
- Wu Hao hot taste, bitter taste, Xin
- the Scriptures records Wu Hao: “Main temperature in the air, pain, cough, cold, heat, dehumidification, blood stasis, wind and evil, Kai Lili.”
- Compendium of Materia Medica records Wu Hao: “Open stagnation, cure phlegm, phlegm and phlegm, headache, yin and stomach pain, phlegm and blood stasis, mouth sore mouth. "There are cold and pain relief, lowering vomiting, used to treat liver and stomach deficiency, yin Headache or stomach cramps caused by turbidity.
- Astragalus membranaceus has the benefits of qi and sun, solid table antiperspirant, diuretic swelling, detoxification and myogenic effects. Indications for all qi deficiency and blood loss, such as spleen deficiency diarrhea, lung deficiency cough, rectal prolapse, uterine ptosis, spontaneous sweating, night sweats, edema, blood stasis, sputum is difficult to collapse or long-term collapse.
- Licorice a kind of tonic Chinese herbal medicine, the medicinal parts are roots and rhizomes.
- the roots of the medicinal properties are cylindrical, with spleen and qi, clearing away heat and detoxification, relieving cough, relieving pain, reconciling the effects of various medicines; Weary fatigue, palpitations, shortness of breath, coughing, abdominal pain, sudden pain in the limbs, swollen sores, relieve drug toxicity, potency and so on. Sanqi, used to stop bleeding and dilated blood, reduce swelling and pain.
- yin deficiency fever dry lung cough, fatigue cough, Tianjin wound thirst, upset insomnia, internal heat and thirst, intestinal dry constipation, lung sputum, lung sputum, diphtheria and other symptoms; inhibition of a variety of bacteria, anti- Tumor activity, can nourish yin and spleen, moisten the lungs and clear the heart, remove dryness and reduce fire.
- Cuttlefish bone containing calcium carbonate, can neutralize stomach acid, relieve symptoms of vomiting and heartburn, promote inflammation of the ulcer surface, prevent bleeding, relieve local pain. It can be used as an antacid.
- Corydalis, temperature, taste, bitterness, liver, spleen, stomach, is a wonderful product of promoting blood circulation, relieving pain and relieving pain, especially known for its anti-pain effect.
- the curative effect is remarkable.
- Jujube, jujube is warm and sweet, contains protein, fat, sugar, calcium, phosphorus, iron, magnesium and rich vitamins.
- the oral solution of the preparation of the present invention is taken half an hour after a meal, 3 times a day, 200 ml each time, 2 months for a course of treatment, and 3 courses of treatment as therapeutic effects.
- the oral solution of the preparation of the present invention is taken half an hour after a meal, 3 times a day, 200 ml each time, 2 months for a course of treatment, and 3 courses for observation of curative effect.
- the beneficial effects of the present invention are that the preparation prepared by the present invention is for treatment Chronic colitis has good effects, and it is non-toxic, has no side effects, and has a stable effect.
- the preparation process is simple and easy. Concrete real
- the preparation of the invention is from Magnolia officinalis, Poria, Evodia, Radix Astragali, Radix Glycyrrhizae, Radix Notoginseng, Rhubarb, Radix Paeoniae Alba, Bergamot, Yam, Chuanxiongzi, Jiangxiang, Jatropha, Asparagus, Skull, Pinellia, Yanhusuo, Shengdi And the preparation of the composition prepared by the red jujube, wherein the mass ratio of each component is: Magnolia 12g ⁇ 10g Wujing 10g Astragalus 12g Licorice 12g Sanqi 15g Rhubarb 10g White Pelican 12g Bergamot 8g Yam 15g Chuanxiong 15g Fragrance 13g Festival Iris 12g asparagus 8g thief bone 10g Pinellia 12g Yanhusuo 13g soil 10g jujube 16g.
- the preparation method of the traditional Chinese medicine preparation for treating chronic colitis includes the following steps: 1) placing the cockroach into a small pot for small frying until the surface is slightly coke, and then pulverizing through a pulverizer and passing through a 80 mesh sieve for use; 2), the magnolia, Wujing, Astragalus, licorice, rhubarb, white peony, bergamot, red dates, pinellia, yanhusuo are proportioned well, pulverized into powder after crushing machine and passed through a 90 mesh sieve, naturally dried, ready for use;
- step 5 mixing the powders of each component in step 4), adding 4 to 6 times 70% ⁇ 80% ethanol, heating and refluxing for 3 to 5 hours, extracting and filtering to obtain a filtrate; and then remaining the dregs Adding 2 to 4 times of 65% to 75% ethanol again, heating and refluxing for 2 to 3 hours, extracting and filtering to obtain a filtrate; combining the filtrates obtained twice, removing the ethanol solvent under reduced pressure, and drying to obtain a dry paste. ;
- the dry paste obtained in the above step 5) is ultra-pulverized into a powder and passed through a 200 mesh sieve, and then the powder is added to the combined decoction in the step 3), and mixed and shaken to obtain.
- the preparation of the above-mentioned traditional Chinese medicine composition solution can be used for oral administration, and if it can be consumed once in the morning and evening and long-term drinking, the effect is better.
- the preferred raw material quality of the present invention is (g):
- the preparation method is as in Example 1.
- the preferred raw material quality of the present invention is (g):
- the preparation method is as in Example 1.
- the preferred raw material quality of the present invention is (g):
- the preparation method is as in Example 1.
- the preferred raw material quality of the present invention is (g):
- the preparation method is as in Example 1.
- the preferred raw material quality of the present invention is (g):
- the preparation method is as in Example 1.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La présente invention concerne une préparation d'un médicament traditionnel chinois destiné à traiter une colite chronique et son procédé de préparation, comprenant du magnolia officinalis, du Wolfiporia extensa, du Tetradium ruticarpum, du Astragalus propinquus, de la réglisse, du Panax notoginseng, de la rhubarbe de grande culture, de la pivoine de Chine, de la main de Bouddha, du Dioscorea opposita, du Melia toosendan, du Dalbergia odorifera, du rhizome d'anémone Altaicae, de l'asparage de Cochinchine, de l'os de seiche, de la pinellie ternée, du Corydalis yanhusuo, du Radix Rehmanniae, et du jujube, lesdits ingrédients étant soumis à des processus de farinage, de décoction, d'extraction à l'éthanol et de mélange en une composition pour préparations liquides.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410124716.2A CN103860844B (zh) | 2014-03-31 | 2014-03-31 | 一种治疗慢性结肠炎的中药制剂及其制备方法 |
CN201410124716.2 | 2014-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015149392A1 true WO2015149392A1 (fr) | 2015-10-08 |
Family
ID=50900231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2014/075339 WO2015149392A1 (fr) | 2014-03-31 | 2014-04-15 | Préparation d'un médicament traditionnel chinois destiné à traiter une colite chronique et son procédé de préparation |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN103860844B (fr) |
WO (1) | WO2015149392A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104623254A (zh) * | 2015-02-26 | 2015-05-20 | 王燕 | 治疗慢性肠炎的中药组合物及制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11139980A (ja) * | 1997-11-04 | 1999-05-25 | Teikoku Seiyaku Co Ltd | 潰瘍性大腸炎治療剤 |
CN102920820A (zh) * | 2012-11-21 | 2013-02-13 | 杨文琳 | 一种治疗慢性结肠炎的中药组合物 |
CN102988870A (zh) * | 2012-11-30 | 2013-03-27 | 北京中融阳光投资管理有限公司 | 一种治疗肝胆胃肠道疾病的口服液 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101422557A (zh) * | 2007-10-29 | 2009-05-06 | 刘芳 | 治疗结肠炎的药物 |
CN101391088B (zh) * | 2008-10-22 | 2010-12-22 | 付道成 | 肠胃炎口服药物 |
-
2014
- 2014-03-31 CN CN201410124716.2A patent/CN103860844B/zh not_active Expired - Fee Related
- 2014-04-15 WO PCT/CN2014/075339 patent/WO2015149392A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11139980A (ja) * | 1997-11-04 | 1999-05-25 | Teikoku Seiyaku Co Ltd | 潰瘍性大腸炎治療剤 |
CN102920820A (zh) * | 2012-11-21 | 2013-02-13 | 杨文琳 | 一种治疗慢性结肠炎的中药组合物 |
CN102988870A (zh) * | 2012-11-30 | 2013-03-27 | 北京中融阳光投资管理有限公司 | 一种治疗肝胆胃肠道疾病的口服液 |
Non-Patent Citations (1)
Title |
---|
QIAN, JINDONG;: "The Study Development of Ulcerative Colitis Treated with TCM", JOURNAL OF PRACTICAL TRADITIONAL CHINESE INTERNAL MEDICINE, vol. 21, no. 1, 28 February 2007 (2007-02-28), pages 21 - 22 * |
Also Published As
Publication number | Publication date |
---|---|
CN103860844A (zh) | 2014-06-18 |
CN103860844B (zh) | 2016-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
CN104187172B (zh) | 用于治疗乌龟肠胃炎病的功能性饲料及其制备方法 | |
CN104288701A (zh) | 一种治疗胆囊炎的中药组合物 | |
CN104042971A (zh) | 用于治疗阴虚毒热型肺癌的药物组合物及其制备方法 | |
WO2015149394A1 (fr) | Liquide oral de médecine traditionnelle chinoise pour le traitement de la gastrite chronique | |
CN104001045A (zh) | 一种用于治疗犬肺炎的药物及其制备方法 | |
CN105214032A (zh) | 治疗消化性溃疡的固体分散片剂 | |
CN104758900A (zh) | 一种用于治疗急性胰腺炎的中药 | |
CN104189413A (zh) | 用于治疗乌龟肠胃炎病的药物组合物及其制备方法 | |
WO2015149393A1 (fr) | Médecine chinoise traditionnelle pour le traitement de la gastrite chronique et son procédé de préparation | |
CN102805834A (zh) | 一种治疗胃炎的药物及其制备方法 | |
CN102846739A (zh) | 一种治疗肝炎的脐贴膏及其制备方法 | |
WO2015149392A1 (fr) | Préparation d'un médicament traditionnel chinois destiné à traiter une colite chronique et son procédé de préparation | |
WO2015149390A1 (fr) | Liquide pour voie oral de médecine chinoise traditionnelle permettant le traitement de l'entérite chronique, et son procédé de préparation | |
CN105233201A (zh) | 治疗消化性溃疡的固体分散颗粒剂 | |
CN105250946A (zh) | 治疗消化性溃疡的固体分散体 | |
CN105214037A (zh) | 治疗消化性溃疡的固体分散胶囊剂 | |
WO2015149391A1 (fr) | Préparation de médecine chinoise traditionnelle pour le traitement de l'entérite chronique et son procédé de préparation | |
CN104707110A (zh) | 一种用于胰腺癌的中药制剂及制备方法 | |
CN103028028B (zh) | 一种治疗原发性肝癌的中药 | |
WO2015149396A1 (fr) | Préparation de médecine chinoise traditionnelle permettant le traitement de la gastrite superficielle, et son procédé de préparation | |
CN107334902A (zh) | 治疗消化系统肿瘤术后胃瘫的中药组合物及其制备方法 | |
CN105012789A (zh) | 治疗宫颈癌的组合物及其制备方法 | |
CN105663551A (zh) | 胰腺癌患者术后服用的中药制剂及制法 | |
CN104606638A (zh) | 一种治疗湿热型急性湿疹的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14887946 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14887946 Country of ref document: EP Kind code of ref document: A1 |